Delek US price target raised to $39 from $36 at Piper Sandler

Piper Sandler raised the firm’s price target on Delek US (DK) to $39 from $36 and keeps an Overweight rating on the shares. The firm notes the company has a history of complicated quarterly results, and Q3 was no exception. While the headline result felt more like an exercise in non-recurring assumptions, even by Delek’s standards, the underlying Q3 result was solid, Piper argues.